4/13, 3:53 PM (Source: TeleTrader)
more TeleTrader news

J&J delays vaccine rollout in Europe

Johnson & Johnson announced on Tuesday that it has decided to "proactively" postpone the rollout of its COVID-19 vaccine in Europe over concerns related to the development of blood clots among rare recipients.

"The safety and well-being of the people who use our products is our number one priority. We are aware of an extremely rare disorder involving people with blood clots in combination with low platelets in a small number of individuals who have received our COVID-19 vaccine," the company said.

According to the United States Food and Drug Administration, six people, out of seven million that received the J&J jab, developed blood clots.

Breaking the News / MD